Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
Get research updatesThis study is completed. It focuses on PTSD and currently lists study information.
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
This summary needs review. Please check the official study record and contact the research team for details.
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)This record does not confirm open recruitment. We can help you understand it and explore other studies.
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)No specific site is confirmed in the available information. Check the official source for locations and remote participation.
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Confirm the location and whether remote participation is possible with the research team.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Based on the public registry summary, this study is trying to understand: Objective: The aims are to examine the feasibility and acceptability of a handheld biofeedback device as an adjunct treatment for Post Traumatic Stress Disorder (PTSD) and to estimate its clinical effect size. A recent summary of 22 studies on OIF/OEF (Operation Iraqi. The study team can confirm the exact objective and what it means for you.
This appears to be a device / app / digital / technology study involving StressEraser. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
This study may concern people with ptsd; age range: From 18 Years to 70 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
You may need to use a device, app, or digital tool for a defined period.
If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
The likely practical burden appears high. Things to check include multiple visits or assessments, questionnaires/interviews/assessments, digital/device data. Ask the study team about duration, visits, possible compensation, data access, and what happens if you want to stop.
This study is sponsored by Central Arkansas Veterans Healthcare System, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me